Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?

Abstract

The objective of our study was to evaluate whether cognitively normal (CN) elderly participants showing elevated cortical beta-amyloid (Aβ) deposition have a consistent neuroanatomical signature of brain atrophy that may characterize preclinical Alzheimer's disease (AD). 115 CN participants who were Aβ-positive (CN +) by amyloid PET imaging; 115 CN participants who were Aβ-negative (CN -); and 88 Aβ-positive mild cognitive impairment or AD participants (MCI/AD +) were identified. Cortical thickness (FreeSurfer) and gray matter volume (SPM5) were measured for 28 regions-of-interest (ROIs) across the brain and compared across groups. ROIs that best discriminated CN - from CN + differed for FreeSurfer cortical thickness and SPM5 gray matter volume. Group-wise discrimination was poor with a high degree of uncertainty in terms of the rank ordering of ROIs. In contrast, both techniques showed strong and consistent findings comparing MCI/AD + to both CN - and CN + groups, with entorhinal cortex, middle and inferior temporal lobe, inferior parietal lobe, and hippocampus providing the best discrimination for both techniques. Concordance across techniques was higher for the CN - and CN + versus MCI/AD + comparisons, compared to the CN - versus CN + comparison. The weak and inconsistent nature of the findings across technique in this study cast doubt on the existence of a reliable neuroanatomical signature of preclinical AD in elderly PiB-positive CN participants.

• Authors: Jennifer L Whitwell, Nirubol Tosakulwong, Stephen D Weigand, Matthew L Senjem, Val J Lowe, Jeffrey L Gunter, Bradley F Boeve, David S Knopman, Bradford C Dickerson, Ronald C Petersen, Clifford R Jack Jr
• Journal: NeuroImage. Clinical (Neuroimage Clin) Vol. 2 Pg. 249-57 ( 2013) ISSN: 2213-1582 [Print] Netherlands
• PMID: 24179779 (Publication Type: Journal Article)